Pursuant to the requirements of the Regulation 30 of the Listing Regulations, as amended, from time to time, Arvaya Healthcare has enclosed a copy of the Investor Presentation issued by the Company in relation with the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026 and overall Company & Business overview, the content of which are self-explanatory.
The above information is a part of company’s filings submitted to BSE.